Several clinico-pathological factors that could affect survival of women diagnosed with non-metastatic breast cancer have been assessed such as: grade, stage, molecular subtypes, HR status, HER2 status, Ki-67 expression, and nodes involvement. The gene discussed is ERBB2; the disease is breast carcinoma.